Inspire Medical Systems, Inc.

NYSE INSP

Inspire Medical Systems, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2024: 0.04

Inspire Medical Systems, Inc. Debt to Equity Ratio is 0.04 for the Trailing 12 Months (TTM) ending September 30, 2024, a 27.58% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Inspire Medical Systems, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.03, a -66.96% change year over year.
  • Inspire Medical Systems, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was 0.09, a -31.73% change year over year.
  • Inspire Medical Systems, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was 0.14, a 1.33% change year over year.
  • Inspire Medical Systems, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2020 was 0.14.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
NYSE: INSP

Inspire Medical Systems, Inc.

CEO Mr. Timothy P. Herbert
IPO Date May 3, 2018
Location United States
Headquarters 5500 Wayzata Boulevard
Employees 1,011
Sector Technology
Industries
Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Similar companies

PODD

Insulet Corporation

USD 287.67

1.04%

TMDX

TransMedics Group, Inc.

USD 73.50

-1.44%

GMED

Globus Medical, Inc.

USD 87.95

-4.82%

INMD

InMode Ltd.

USD 18.25

1.62%

DXCM

DexCom, Inc.

USD 88.32

-0.52%

TNDM

Tandem Diabetes Care, Inc.

USD 36.74

0.14%

NARI

Inari Medical, Inc.

USD 79.87

-0.03%

PEN

Penumbra, Inc.

USD 261.50

-1.67%

NVCR

NovoCure Limited

USD 24.52

-3.88%

CLPT

ClearPoint Neuro, Inc.

USD 18.90

0.53%

GKOS

Glaukos Corporation

USD 155.28

-1.17%

StockViz Staff

February 7, 2025

Any question? Send us an email